Snovitra: Advanced Therapy for Erectile Dysfunction
Snovitra
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.68 | $41.00 (0%) | 🛒 Add to cart |
| 90 | $0.54 | $61.50 $49.00 (20%) | 🛒 Add to cart |
| 120 | $0.43 | $82.00 $52.00 (37%) | 🛒 Add to cart |
| 180 | $0.31 | $123.00 $56.00 (54%) | 🛒 Add to cart |
| 270 | $0.22 | $184.50 $60.00 (67%) | 🛒 Add to cart |
| 360 | $0.18
Best per pill | $246.00 $64.00 (74%) | 🛒 Add to cart |
| Product dosage: 40mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.98 | $59.00 (0%) | 🛒 Add to cart |
| 90 | $0.80 | $88.50 $72.00 (19%) | 🛒 Add to cart |
| 120 | $0.69 | $118.00 $83.00 (30%) | 🛒 Add to cart |
| 180 | $0.56 | $177.00 $101.00 (43%) | 🛒 Add to cart |
| 270 | $0.46 | $265.50 $124.00 (53%) | 🛒 Add to cart |
| 360 | $0.38
Best per pill | $354.00 $136.00 (62%) | 🛒 Add to cart |
Snovitra (vardenafil) is a prescription phosphodiesterase type 5 (PDE5) inhibitor specifically formulated for the treatment of erectile dysfunction. It works by enhancing blood flow to the penile tissues during sexual stimulation, facilitating the achievement and maintenance of an erection sufficient for satisfactory sexual activity. Clinically proven and widely prescribed, Snovitra offers a reliable therapeutic option for men seeking to restore sexual function and improve quality of life. Its optimized pharmacokinetic profile ensures rapid onset and sustained duration of action, making it a preferred choice among healthcare providers and patients alike.
Features
- Active ingredient: Vardenafil hydrochloride
- Available in 10mg, 20mg, and 40mg film-coated tablets
- Rapid onset of action, typically within 25–60 minutes
- Duration of efficacy up to 4–5 hours
- High selectivity for PDE5 enzyme inhibition
- Manufactured under strict GMP (Good Manufacturing Practice) standards
- Bioequivalent to branded vardenafil formulations
- Dispersible tablet option for enhanced absorption
Benefits
- Effectively facilitates the physiological process of achieving and maintaining an erection when sexually aroused.
- Improves confidence and reduces anxiety related to sexual performance.
- Enhances overall sexual satisfaction for both partners.
- Supports long-term intimate relationship quality and psychological well-being.
- Provides predictable and reliable results with proper use.
- Allows for spontaneity in sexual activity due to its rapid onset and extended window of efficacy.
Common use
Snovitra is indicated for the management of erectile dysfunction (ED) in adult men. Erectile dysfunction is characterized by the consistent or recurrent inability to attain and/or maintain a penile erection sufficient for satisfactory sexual performance. The medication is suitable for various etiologies of ED, including vasculogenic, neurogenic, and psychogenic causes, as well as mixed etiologies. It is not intended for use by women, children, or adolescents. Sexual stimulation is required for Snovitra to be effective; it does not trigger an automatic erection.
Dosage and direction
The recommended starting dose of Snovitra is 10mg, taken orally approximately 25–60 minutes before anticipated sexual activity. Based on efficacy and tolerability, the dose may be increased to a maximum of 40mg or decreased to 5mg. Do not exceed one dose per 24-hour period. The tablet should be swallowed whole with a glass of water; it may be taken with or without food, though high-fat meals may delay onset of action. For the dispersible formulation, place the tablet on the tongue and allow it to dissolve; swallowing is not required. Adherence to prescribed dosage is critical for safety and effectiveness.
Precautions
Prior to initiating treatment with Snovitra, a thorough medical evaluation should be conducted to diagnose erectile dysfunction, identify potential underlying causes, and assess cardiovascular health. Use with caution in patients with anatomical deformation of the penis (e.g., angulation, cavernosal fibrosis, or Peyronie’s disease), conditions that may predispose to priapism (e.g., sickle cell anemia, multiple myeloma, leukemia), or bleeding disorders. Cardiovascular status must be evaluated since sexual activity carries potential cardiac risk. Patients with severe hepatic impairment (Child-Pugh class C) should not exceed a 5mg dose. Snovitra may cause dizziness and visual disturbances; caution is advised when driving or operating machinery.
Contraindications
Snovitra is contraindicated in patients with a known hypersensitivity to vardenafil or any excipients in the formulation. Concomitant administration with organic nitrates or nitric oxide donors (e.g., amyl nitrite) in any form is strictly contraindicated due to the risk of profound hypotension. It is also contraindicated in patients taking guanylate cyclase stimulators, such as riociguat. Use is prohibited in individuals with severe hepatic impairment, end-stage renal disease requiring dialysis, hypotension (BP <90/50 mmHg), recent stroke or myocardial infarction, unstable angina, or life-threatening arrhythmias.
Possible side effects
Common adverse reactions (≥2%) include headache, flushing, rhinitis, dyspepsia, and dizziness. Less frequently, patients may experience visual disturbances (e.g., color tinge, blurred vision), nausea, back pain, myalgia, or increased creatine kinase. Although rare, serious side effects can occur, including priapism (prolonged and painful erection lasting more than 4 hours), sudden hearing loss, tinnitus, non-arteritic anterior ischemic optic neuropathy (NAION), and cardiovascular events like angina or hypotension. Any unusual or severe symptoms should prompt immediate medical attention.
Drug interaction
Snovitra is primarily metabolized by CYP3A4 enzymes. Concomitant use with potent CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, ritonavir, clarithromycin) significantly increases vardenafil plasma concentrations—dose adjustment is necessary. Avoid use with moderate CYP3A4 inhibitors. Alpha-blockers (e.g., doxazosin, tamsulosin) may potentiate hypotensive effects; concomitant use should be approached with caution. Other antihypertensives may have additive blood pressure-lowering effects. Avoid combining with other PDE5 inhibitors. Grapefruit juice may increase bioavailability and should be avoided.
Missed dose
Snovitra is taken on an as-needed basis prior to sexual activity; it is not intended for daily scheduled dosing. Therefore, the concept of a “missed dose” does not apply. Do not take extra tablets to make up for a missed opportunity. Adhere strictly to the prescribed dosing schedule of no more than one tablet within a 24-hour period.
Overdose
In cases of overdose, standard supportive measures should be employed. Expected effects would be an extension of the drug’s vasodilatory properties, including severe hypotension, syncope, and potentially irreversible cardiovascular complications. Management includes maintaining supine position and providing intravenous fluids if necessary. Hemodialysis is not expected to significantly accelerate elimination due to high protein binding and extensive tissue distribution. Symptomatic treatment for hypotension may require vasopressors under clinical supervision. Immediately contact a poison control center or emergency medical services.
Storage
Store Snovitra tablets at room temperature (15–30°C or 59–86°F) in the original blister packaging to protect from light and moisture. Keep out of reach of children and pets. Do not use beyond the expiration date printed on the packaging. Properly dispose of any unused or expired medication in accordance with local regulations; do not flush down the toilet or drain unless instructed.
Disclaimer
This information is intended for educational purposes only and does not constitute medical advice. Snovitra is a prescription medication and should only be used under the supervision of a qualified healthcare professional. Always follow the specific instructions provided by your prescribing physician. Do not initiate, discontinue, or alter your dosage without consulting your healthcare provider. The manufacturer is not liable for any misuse, adverse outcomes, or inaccuracies in self-diagnosis or self-treatment.
Reviews
Clinical studies and patient reports consistently highlight the efficacy and tolerability of Snovitra. In randomized, double-blind, placebo-controlled trials, a significant proportion of men treated with vardenafil reported improved erections and successful intercourse attempts. Users often note its rapid action and reliability. However, individual experiences may vary based on underlying health conditions, adherence to dosing instructions, and psychological factors. Always refer to your physician for personalized advice and to discuss whether Snovitra is appropriate for your specific health profile.